Option delistings effective September 25th include Phio Pharmaceuticals Corp (PHIO), ESG Orphans ETF (ORFN), Oblong (OBLG), New York City REIT (NYC), NuZee (NUZE), Moatable Inc (MTBL), Marker Therapeutics (MRKR), Mercurity Fintech Holdings (MFH), Mustang Bio (MBIO), Liminal BioSciences (LMNL), Lucira Health Inc (LHDXQ), Kiromic Biopharma Inc (KRBP), Imv Inc (IMVIQ), Hallmark Financial (HALL), Engine Media Holdings (GAME), iShares MSCI Emerging Markets Asia (EEMA), Dave Inc. (DAVE), ComSovereign Holding Corp (COMS), SPDR Kensho Clean Power ETF (CNRG), ChinaNet Online (CNET), Ci Financial Corporation (CIXXF), CHARAH SOLUTIONS INC. (CHRA), ContraFect (CFRX), Codiak Biosciences, Inc. (CDAKQ), Canon Inc (ADR) (CAJPY), Breakwave Sea Deacarbonization ETF (BSEA), Breeze Holdings Acquisition Corp (BREZ), AYTU BioPharma (AYTU), Avalo Therapeutics (AVTX), Athenex Inc (ATNXQ), Ascent Solar Tech. (ASTI), Altisource (ASPS), Aceragen Inc (ACGN), Reed‘S Inc (REED), Arcadia Biosciences (RKDA), Rubius Therapeutics Inc (RUBY), Statera Biopharma Inc (STAB), Steel Connect (STCN), SWVL Holdings Corp (SWVL), Tuesday Morning Corp (TUEMQ), Via Renewables (VIA), VYNE Therapeutics (VYNE), and Xinyuan Real Estate (XIN).
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on PHIO:
- Phio CEO to Speak at Wainwright Conference in New York in September
- Phio Pharmaceuticals Announces Dosing of First Patient in Collaborative Clinical Trial with AgonOx, Inc. and Providence Cancer Institute
- Phio announces dosing of first patient in trial with AgonOx, Providence Cancer
- Phio Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Business Update